JP2012502090A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012502090A5 JP2012502090A5 JP2011526590A JP2011526590A JP2012502090A5 JP 2012502090 A5 JP2012502090 A5 JP 2012502090A5 JP 2011526590 A JP2011526590 A JP 2011526590A JP 2011526590 A JP2011526590 A JP 2011526590A JP 2012502090 A5 JP2012502090 A5 JP 2012502090A5
- Authority
- JP
- Japan
- Prior art keywords
- fatty acid
- capsule
- emulsion
- weight
- oil mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 83
- 239000003921 oil Substances 0.000 claims 82
- 235000019198 oils Nutrition 0.000 claims 82
- 239000000194 fatty acid Substances 0.000 claims 77
- 239000002775 capsule Substances 0.000 claims 74
- 235000014113 dietary fatty acids Nutrition 0.000 claims 74
- 150000004665 fatty acids Chemical class 0.000 claims 67
- 239000000839 emulsion Substances 0.000 claims 54
- 229960005135 Eicosapentaenoic Acid Drugs 0.000 claims 41
- JAZBEHYOTPTENJ-JLNKQSITSA-N Eicosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims 41
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims 41
- MBMBGCFOFBJSGT-KUBAVDMBSA-N Docosahexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims 36
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims 32
- 229960004363 doconexent Drugs 0.000 claims 25
- 229940090949 docosahexaenoic acid Drugs 0.000 claims 25
- 239000004094 surface-active agent Substances 0.000 claims 25
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 21
- 229920000615 alginic acid Polymers 0.000 claims 18
- 150000004676 glycans Polymers 0.000 claims 16
- 239000012528 membrane Substances 0.000 claims 16
- 229920001282 polysaccharide Polymers 0.000 claims 16
- 239000005017 polysaccharide Substances 0.000 claims 16
- 150000004804 polysaccharides Polymers 0.000 claims 16
- 229940072056 alginate Drugs 0.000 claims 14
- 235000010443 alginic acid Nutrition 0.000 claims 14
- -1 glycerol fatty acid ester Chemical class 0.000 claims 13
- 235000017788 Cydonia oblonga Nutrition 0.000 claims 10
- 240000000590 Cydonia oblonga Species 0.000 claims 10
- 210000003097 Mucus Anatomy 0.000 claims 10
- UXVMQQNJUSDDNG-UHFFFAOYSA-L cacl2 Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 9
- 239000007764 o/w emulsion Substances 0.000 claims 8
- 125000004494 ethyl ester group Chemical group 0.000 claims 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Substances OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 6
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims 6
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims 6
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 6
- 229920000053 polysorbate 80 Polymers 0.000 claims 6
- 150000003626 triacylglycerols Chemical class 0.000 claims 6
- 230000000813 microbial Effects 0.000 claims 5
- 235000015112 vegetable and seed oil Nutrition 0.000 claims 5
- 239000008158 vegetable oil Substances 0.000 claims 5
- 206010007554 Cardiac failure Diseases 0.000 claims 4
- 206010019280 Heart failure Diseases 0.000 claims 4
- 208000006575 Hypertriglyceridemia Diseases 0.000 claims 4
- 239000004014 plasticizer Substances 0.000 claims 4
- DTOSIQBPPRVQHS-PDBXOOCHSA-N α-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims 4
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 claims 3
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 claims 3
- BVDRUCCQKHGCRX-UHFFFAOYSA-N 2,3-dihydroxypropyl formate Chemical compound OCC(O)COC=O BVDRUCCQKHGCRX-UHFFFAOYSA-N 0.000 claims 3
- KUXGUCNZFCVULO-UHFFFAOYSA-N 2-(4-nonylphenoxy)ethanol Chemical compound CCCCCCCCCC1=CC=C(OCCO)C=C1 KUXGUCNZFCVULO-UHFFFAOYSA-N 0.000 claims 3
- 206010013637 Dressler's syndrome Diseases 0.000 claims 3
- 102000004877 Insulin Human genes 0.000 claims 3
- 108090001061 Insulin Proteins 0.000 claims 3
- 229940026235 PROPYLENE GLYCOL MONOLAURATE Drugs 0.000 claims 3
- 210000002381 Plasma Anatomy 0.000 claims 3
- 239000002202 Polyethylene glycol Substances 0.000 claims 3
- 229920001451 Polypropylene glycol Polymers 0.000 claims 3
- 229920001213 Polysorbate 20 Polymers 0.000 claims 3
- 229940068977 Polysorbate 20 Drugs 0.000 claims 3
- 229920001219 Polysorbate 40 Polymers 0.000 claims 3
- 229940068968 Polysorbate 80 Drugs 0.000 claims 3
- 230000002159 abnormal effect Effects 0.000 claims 3
- 230000000271 cardiovascular Effects 0.000 claims 3
- 235000015872 dietary supplement Nutrition 0.000 claims 3
- LLRANSBEYQZKFY-UHFFFAOYSA-N dodecanoic acid;propane-1,2-diol Chemical compound CC(O)CO.CCCCCCCCCCCC(O)=O LLRANSBEYQZKFY-UHFFFAOYSA-N 0.000 claims 3
- 150000002148 esters Chemical class 0.000 claims 3
- 235000021323 fish oil Nutrition 0.000 claims 3
- 230000036737 immune function Effects 0.000 claims 3
- 150000002632 lipids Chemical class 0.000 claims 3
- 150000004668 long chain fatty acids Chemical class 0.000 claims 3
- 229960003511 macrogol Drugs 0.000 claims 3
- 229920000847 nonoxynol Polymers 0.000 claims 3
- FSVSNKCOMJVGLM-UHFFFAOYSA-N octanoic acid;propane-1,2-diol Chemical compound CC(O)CO.CCCCCCCC(O)=O FSVSNKCOMJVGLM-UHFFFAOYSA-N 0.000 claims 3
- 125000002811 oleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 3
- 150000003904 phospholipids Chemical class 0.000 claims 3
- 239000008389 polyethoxylated castor oil Substances 0.000 claims 3
- 229920001223 polyethylene glycol Polymers 0.000 claims 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims 3
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 claims 3
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 claims 3
- 229940101027 polysorbate 40 Drugs 0.000 claims 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Substances CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 3
- 230000001105 regulatory Effects 0.000 claims 3
- 230000004382 visual function Effects 0.000 claims 3
- YEKFYCQGYMVFKR-MBFZXKRTSA-N (2E,4E,6E,8E,10E)-docosa-2,4,6,8,10-pentaenoic acid Chemical compound CCCCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C(O)=O YEKFYCQGYMVFKR-MBFZXKRTSA-N 0.000 claims 2
- ZCDMRPMKAQLWAO-PZLFCYFRSA-N (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid;(9Z,12Z)-octadeca-9,12-dienoic acid Chemical class CCCCC\C=C/C\C=C/CCCCCCCC(O)=O.CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O ZCDMRPMKAQLWAO-PZLFCYFRSA-N 0.000 claims 2
- OQOCQFSPEWCSDO-JLNKQSITSA-N (6Z,9Z,12Z,15Z,18Z)-henicosa-6,9,12,15,18-pentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCC(O)=O OQOCQFSPEWCSDO-JLNKQSITSA-N 0.000 claims 2
- 235000021294 Docosapentaenoic acid Nutrition 0.000 claims 2
- 229960004488 Linolenic Acid Drugs 0.000 claims 2
- 229940033080 Omega-6 Fatty Acids Drugs 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 239000000654 additive Substances 0.000 claims 2
- 230000000996 additive Effects 0.000 claims 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims 2
- 239000003963 antioxidant agent Substances 0.000 claims 2
- 239000003086 colorant Substances 0.000 claims 2
- 235000003599 food sweetener Nutrition 0.000 claims 2
- 239000003349 gelling agent Substances 0.000 claims 2
- IQLUYYHUNSSHIY-UHFFFAOYSA-N icosa-2,4,6,8-tetraenoic acid Chemical compound CCCCCCCCCCCC=CC=CC=CC=CC(O)=O IQLUYYHUNSSHIY-UHFFFAOYSA-N 0.000 claims 2
- 235000020665 omega-6 fatty acid Nutrition 0.000 claims 2
- 239000004848 polyfunctional curative Substances 0.000 claims 2
- 239000003381 stabilizer Substances 0.000 claims 2
- 239000003765 sweetening agent Substances 0.000 claims 2
- SSQPWTVBQMWLSZ-AAQCHOMXSA-N Ethyl eicosapentaenoic acid Chemical compound CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC SSQPWTVBQMWLSZ-AAQCHOMXSA-N 0.000 claims 1
- 229920000064 Ethyl eicosapentaenoic acid Polymers 0.000 claims 1
- 206010061216 Infarction Diseases 0.000 claims 1
- 210000004165 Myocardium Anatomy 0.000 claims 1
- 229940012843 Omega-3 Fatty Acids Drugs 0.000 claims 1
- 229940067631 Phospholipids Drugs 0.000 claims 1
- 230000000111 anti-oxidant Effects 0.000 claims 1
- 230000003078 antioxidant Effects 0.000 claims 1
- TYLNXKAVUJJPMU-PWQIQEKYSA-N ethyl (2Z,4Z,6Z,8Z,10Z,12E)-docosa-2,4,6,8,10,12-hexaenoate Chemical compound CCCCCCCCC\C=C\C=C/C=C\C=C/C=C\C=C/C(=O)OCC TYLNXKAVUJJPMU-PWQIQEKYSA-N 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 239000006014 omega-3 oil Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/207,824 US20100062057A1 (en) | 2008-09-10 | 2008-09-10 | Formulation |
| US12/207,824 | 2008-09-10 | ||
| PCT/IB2009/006933 WO2010029433A1 (en) | 2008-09-10 | 2009-09-10 | A polysaccharide capsule enclosing a fatty acid oil-containing emulsion |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012502090A JP2012502090A (ja) | 2012-01-26 |
| JP2012502090A5 true JP2012502090A5 (es) | 2012-11-01 |
Family
ID=41799505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011526590A Pending JP2012502090A (ja) | 2008-09-10 | 2009-09-10 | 脂肪酸油含有乳剤を封入した多糖類カプセル |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20100062057A1 (es) |
| EP (1) | EP2341901A4 (es) |
| JP (1) | JP2012502090A (es) |
| KR (1) | KR20110058881A (es) |
| CN (1) | CN102209534A (es) |
| AU (1) | AU2009290542A1 (es) |
| BR (1) | BRPI0918429A2 (es) |
| CA (1) | CA2736812A1 (es) |
| EA (1) | EA201170433A1 (es) |
| MX (1) | MX2011002640A (es) |
| WO (1) | WO2010029433A1 (es) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2405902B1 (en) | 2009-03-09 | 2021-07-21 | Basf As | Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof |
| WO2011031621A2 (en) * | 2009-09-10 | 2011-03-17 | Fmc Corporation | High strength seamless alginate capsules |
| KR102073938B1 (ko) * | 2009-10-23 | 2020-02-05 | 바스프 에이에스 | 지방산 오일 혼합물의 코팅된 캡슐 및 정제 |
| MX2012005065A (es) * | 2009-10-30 | 2012-06-13 | Tharos Ltd | Proceso sin solventes para la obtencion de aceites de krill enriquecidos con fosfolipidos y lipidos neutros. |
| DE102010001179A1 (de) * | 2010-01-25 | 2011-07-28 | Technische Universität Dresden, 01069 | Verwendung von Hydrogelen auf Basis guluronsäure- und/oder mannuronsäurehaltiger Polysaccharide zur Behandlung von Beschädigungen des Nervensystems, zur Förderung des Nervenwachstums, zur Behandlung von neurodegenerativen Erkrankungen und zur Kultivierung von Neuronen |
| GB201006204D0 (en) * | 2010-04-14 | 2010-06-02 | Ayanda As | Composition |
| CA3065589C (en) | 2010-06-03 | 2022-04-26 | Catalent Ontario Limited | Multi phase soft gel capsules, apparatus and method thereof |
| CA2706270C (en) * | 2010-06-03 | 2020-01-07 | Accucaps Industries Limited | Pharmaceutical formulations of statins and omega-3 fatty acids for encapsulation |
| EP2658404B1 (en) | 2010-12-29 | 2015-12-16 | Abbott Laboratories | Nutritional products including a novel fat system including monoglycerides |
| ITMI20111050A1 (it) | 2011-06-10 | 2012-12-11 | Sevecom Spa | Uso di emulsionanti in associazione con oleine vegetali in un alimento per animali. |
| US8895074B2 (en) * | 2011-06-15 | 2014-11-25 | Stable Solutions Llc | Therapeutic application of parenteral krill oil |
| US10052352B2 (en) | 2011-06-15 | 2018-08-21 | Stable Solutions Llc | Therapeutic application of parenteral krill oil |
| SI2720701T1 (sl) * | 2011-06-15 | 2017-12-29 | Stable Solutions Llc | Terapevtska parenteralna uporaba krill olja |
| EP2793867B1 (en) | 2011-12-22 | 2021-01-20 | Baes, Erik | Gelatin/alginate delayed release capsules comprising omega-3 fatty acids, and methods and uses thereof |
| BR112014016788A8 (pt) | 2012-01-06 | 2017-07-04 | Chrysalis Pharma Ag | composições de ácidos graxos poli-insaturados ômega-3 em forma de ácido livre, enriquecidas com dpa |
| US9849018B2 (en) * | 2012-02-21 | 2017-12-26 | Allurion Technologies, Inc. | Ingestible delivery systems and methods |
| SG11201404821UA (en) | 2012-02-21 | 2014-09-26 | Allurion Technologies Inc | Methods and devices for deploying and releasing a temporary implant within the body |
| US10182932B2 (en) | 2012-02-21 | 2019-01-22 | Allurion Technologies, Inc. | Methods and devices for deploying and releasing a temporary implant within the body |
| JPWO2013129168A1 (ja) * | 2012-02-29 | 2015-07-30 | 日清オイリオグループ株式会社 | カプセル食品およびカプセル含有油脂組成物 |
| AU2013235266B2 (en) | 2012-03-20 | 2017-10-19 | Particle Dynamics International, Llc | Gelling agent-based dosage form |
| US20160228397A1 (en) | 2012-03-30 | 2016-08-11 | Sancilio & Company, Inc. | Omega-3 fatty acid ester compositions |
| MY189576A (en) | 2012-03-30 | 2022-02-17 | Micelle Biopharma Inc | Omega-3 fatty acid ester compositions |
| US9480651B2 (en) | 2012-03-30 | 2016-11-01 | Sancilio & Company, Inc. | Omega-3 fatty acid ester compositions unitary pharmaceutical dosage forms |
| US10898458B2 (en) | 2012-03-30 | 2021-01-26 | Micelle Biopharma, Inc. | Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states |
| EP2846779A4 (en) | 2012-05-07 | 2015-12-16 | Omthera Pharmaceuticals Inc | STATIN AND OMEGA-3 FATTY ACID COMPOSITIONS |
| EP2866800A4 (en) * | 2012-06-29 | 2015-12-16 | Amarin Pharmaceuticals Ie Ltd | METHOD FOR THE TREATMENT OF METABOLIC SYNDROME IN CHILDREN |
| GB201216385D0 (en) * | 2012-09-13 | 2012-10-31 | Chrysalis Pharma Ag | A pharmaceutical composition |
| KR102506474B1 (ko) | 2014-07-21 | 2023-03-06 | 세베콤 에스.피.에이. | 동물 사료용 분말형 에멀젼 |
| CN107106501B (zh) * | 2014-12-23 | 2021-07-06 | 杜邦营养美国有限公司 | 肠溶膜包衣组合物、包覆方法以及包覆的制剂 |
| MA41611A (fr) * | 2015-02-23 | 2018-01-02 | Omthera Pharmaceuticals Inc | Préparations en milli-capsules comprenant des acides gras polyinsaturés libres |
| US20180042851A1 (en) * | 2015-03-12 | 2018-02-15 | Fmc Corporation | Solid dispersions |
| GB201509606D0 (en) * | 2015-06-03 | 2015-07-15 | Anabio Technologies Ltd | Microencapsulates containing stabilised marine-derived oil, and methods for production thereof |
| ES2607715B1 (es) * | 2015-10-01 | 2018-01-17 | Solutex Na, Lcc | Proceso para la preparación y estabilización de emulsiones con omega-3 mediante redes cristalinas isométricas de derivados de celulosa |
| KR101634314B1 (ko) * | 2015-10-22 | 2016-06-30 | 한방약초힐링 농업회사법인주식회사 | 식물성 오메가-3 함유 기능성 미세분말 제조방법 |
| US20180325785A1 (en) * | 2015-11-25 | 2018-11-15 | Asanuma Corporation | Method for manufacturing capsule |
| WO2019165449A1 (en) | 2018-02-26 | 2019-08-29 | Allurion Technologies, Inc. | Automatic-sealing balloon-filling catheter system |
| US11980691B2 (en) | 2018-03-15 | 2024-05-14 | R.P. Scherer Technologies, Llc | Enteric softgel capsules |
| CN108704588B (zh) * | 2018-06-29 | 2020-10-09 | 广西壮族自治区林业科学研究院 | 一种微胶囊化酸性水溶液的制备方法 |
| EP4295820A3 (en) | 2018-07-06 | 2024-02-28 | Allurion Technologies, Inc. | Binary fluid control valve system |
| EP3886774A4 (en) | 2018-12-13 | 2022-09-28 | Allurion Technologies, Inc. | ENHANCED FLUID DELIVERY SYSTEM |
| US20220192998A1 (en) * | 2019-04-30 | 2022-06-23 | Dsm Ip Assets B.V. | New delivery system for polyunsaturated fatty acids |
| WO2021220236A1 (en) * | 2020-05-01 | 2021-11-04 | Cadila Healthcare Limited | Pharmaceutical compositions for combination therapy |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1015251A (en) * | 1963-03-12 | 1965-12-31 | Glaxo Lab Ltd | Aqueous pharmaceutical compositions in capsule form |
| US3682654A (en) * | 1970-03-13 | 1972-08-08 | Gen Mills Inc | Artificial flavored berries and process of preparing same |
| US4507327A (en) * | 1983-05-23 | 1985-03-26 | Q.P. Corporation | Process for preparing edible products in the form of capsules |
| JPS60100516A (ja) * | 1983-11-04 | 1985-06-04 | Takeda Chem Ind Ltd | 徐放型マイクロカプセルの製造法 |
| JPS6121070A (ja) * | 1984-07-11 | 1986-01-29 | Q P Corp | 魚卵様食品の製法 |
| GB2209937B (en) * | 1987-09-21 | 1991-07-03 | Depiopharm S A | Water insoluble polypeptides |
| DE3876941D1 (de) * | 1987-10-28 | 1993-02-04 | Solvay Umweltchemie Gmbh | Zur selektiven abtrennung von metallkationen aus waessrigen loesungen geeignetes teilchenfoermiges mittel, verfahren zu seiner herstellung und seine verwendung. |
| GB8819110D0 (en) * | 1988-08-11 | 1988-09-14 | Norsk Hydro As | Antihypertensive drug & method for production |
| KR930006431B1 (ko) * | 1990-10-11 | 1993-07-16 | 재단법인 한국화학연구소 | 약물의 미세캡슐화 방법 |
| CH683149A5 (fr) * | 1991-07-22 | 1994-01-31 | Debio Rech Pharma Sa | Procédé pour la préparation de microsphères en matériau polymère biodégradable. |
| EP0573978B1 (en) * | 1992-06-12 | 1999-04-21 | Kao Corporation | Bath additive composition comprising surfactant-containing seamless capsules and method for producing the capsules. |
| MY118354A (en) * | 1995-05-01 | 2004-10-30 | Scarista Ltd | 1,3-propane diol derivatives as bioactive compounds |
| JP3238350B2 (ja) * | 1997-05-27 | 2001-12-10 | 三粧化研株式会社 | 可食性パール状カプセルおよびその製造法 |
| JP4309045B2 (ja) * | 1997-10-30 | 2009-08-05 | 森下仁丹株式会社 | 不飽和脂肪酸またはその誘導体を内容物とするカプセル製剤およびその製造法 |
| CA2313024C (en) * | 1997-12-10 | 2008-06-03 | Severson, Mary L. | Pharmaceutical compositions containing an omega-3 fatty acid oil |
| US6214376B1 (en) * | 1998-08-25 | 2001-04-10 | Banner Pharmacaps, Inc. | Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture |
| ES2253147T3 (es) * | 2000-03-04 | 2006-06-01 | Cognis Ip Management Gmbh | Microcapsulas. |
| US7264824B1 (en) * | 2000-04-13 | 2007-09-04 | Meduna Arzneimittel Gmbh | Oral dosage form |
| ATE305810T1 (de) * | 2000-05-22 | 2005-10-15 | Pro Aparts Investimentos E Con | Fettsäure enthaltende pharmazeutische zusammensetzung die wenigstens 80 gew. epa und dha enthält |
| AR039170A1 (es) * | 2002-03-28 | 2005-02-09 | Bio Dar Ltd | Co-granulos de dha y romero y metodos de uso |
| NO20021592D0 (no) * | 2002-04-04 | 2002-04-04 | Fmc Biopolymer As | Polysakkaridkapsler og fremgangsmåte ved fremstilling derav |
| US6974592B2 (en) * | 2002-04-11 | 2005-12-13 | Ocean Nutrition Canada Limited | Encapsulated agglomeration of microcapsules and method for the preparation thereof |
| JP4634796B2 (ja) * | 2002-06-24 | 2011-02-16 | 中外製薬株式会社 | 非球形シームレスカプセルの製造装置 |
| US7431986B2 (en) * | 2002-07-24 | 2008-10-07 | General Mills, Inc. | Encapsulation of sensitive components using pre-emulsification |
| EP1572164A2 (en) * | 2002-12-18 | 2005-09-14 | Pain Therapeutics, Inc. | Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats |
| US20040254357A1 (en) * | 2002-12-19 | 2004-12-16 | Zaloga Gary P. | Fatty acid phenolic conjugates |
| ITMI20031617A1 (it) * | 2003-08-06 | 2005-02-07 | Fond Carlo E Dirce Callerio Onlus | Microcapsule a doppio strato di polisaccaridi utilizzabili |
-
2008
- 2008-09-10 US US12/207,824 patent/US20100062057A1/en not_active Abandoned
-
2009
- 2009-09-10 EA EA201170433A patent/EA201170433A1/ru unknown
- 2009-09-10 AU AU2009290542A patent/AU2009290542A1/en not_active Abandoned
- 2009-09-10 JP JP2011526590A patent/JP2012502090A/ja active Pending
- 2009-09-10 BR BRPI0918429A patent/BRPI0918429A2/pt not_active IP Right Cessation
- 2009-09-10 CA CA2736812A patent/CA2736812A1/en not_active Abandoned
- 2009-09-10 WO PCT/IB2009/006933 patent/WO2010029433A1/en active Application Filing
- 2009-09-10 US US13/062,997 patent/US20110262534A1/en not_active Abandoned
- 2009-09-10 EP EP09812757.4A patent/EP2341901A4/en not_active Withdrawn
- 2009-09-10 CN CN2009801446021A patent/CN102209534A/zh active Pending
- 2009-09-10 KR KR1020117008242A patent/KR20110058881A/ko not_active Application Discontinuation
- 2009-09-10 MX MX2011002640A patent/MX2011002640A/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012502090A5 (es) | ||
| US20210128510A1 (en) | Self-emulsifying composition of omega3 fatty acid | |
| US20110262534A1 (en) | polysaccharide capsule enclosing a fatty acid oil-containing emulsion | |
| JP2022121571A (ja) | ω３脂肪酸の自己乳化組成物 | |
| JP2012519728A5 (es) | ||
| EP3062785B1 (en) | Enteric soft capsules comprising polyunsaturated fatty acids | |
| US20040209953A1 (en) | Glyceride compositions and methods of making and using same | |
| JP2015520235A5 (es) | ||
| KR20210083395A (ko) | 지방산 오일 혼합물의 코팅된 캡슐 및 정제 | |
| JP2011519349A5 (es) | ||
| JP2013538817A5 (es) | ||
| US9044043B2 (en) | Balanced fat composition and use thereof in a liquid nutritional composition suitable for enteral feeding | |
| WO2013072767A1 (en) | Compositions and preconcentrates comprising at least one salicylate and omega-3 fatty acid oil mixture | |
| JP2014125579A (ja) | 油脂の酸化防止剤 | |
| JP2021137035A5 (ja) | 高度不飽和脂肪酸のトリグリセリドを含む組成物 | |
| JP2016501248A5 (es) | ||
| JP2011006380A (ja) | ω３脂肪酸の乳化組成物 | |
| JP2012508791A5 (es) | ||
| WO2014095628A1 (en) | Oral formulation containing a statin in omega-3 polyunsaturated fatty acids (n-3 pufa) | |
| JPWO2009031275A1 (ja) | 抗酸化剤 | |
| WO2011128626A1 (en) | Essential fatty acid gelled composition | |
| JP2017516820A5 (es) | ||
| RU2017145265A (ru) | Фармацевтические композиции, содержащие epa и сердечно-сосудистое средство, и способы их применения | |
| JP2021084895A (ja) | ω３脂肪酸の自己乳化製剤 | |
| Lemieux et al. | PHARMACOKINETIC, SAFETY AND EFFICACY DATA OF CAPRE (R), A NOVEL INVESTIGATIONAL OMEGA-3 DRUG DERIVED FROM KRILL OIL |